FindMyKOL

John Reynolds, MD

Enriched profile

Consultant General Surgeon · Beacon Hospital

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Bismarck, ND · Midwest · United StatesSpecialtyHematology / OncologyFocusEsophageal Neoplasms+4
Active KOLFindMyKOL type: RegionalLatest publicationNone indexedOnline presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

John Reynolds is Consultant General Surgeon at Beacon Hospital. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 12 Nov 2026

Overview

Updated 17 Nov 2026

John Reynolds, MD, is Consultant General Surgeon at Beacon Hospital, Dublin. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 17 companies.

  • Top research focus: Esophageal Neoplasms
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 17 companies

Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Brain Neoplasms1 trialCarcinoma, Squamous Cell1 trialEsophageal Neoplasms1 trialEsophageal Squamous Cell Carcinoma1 trialNeoplasm Metastasis1 trial

Research focus

OpenAlex concept fingerprint
Esophageal NeoplasmsGastroesophageal CancerStomach NeoplasmsDuodenal NeoplasmsPancreatic Cancer

Drugs & molecules

across trials, industry payments and publications
Opdivogeneric · NivolumabClinical trials—Industry payments5Publications—Enhertugeneric · TrastuzumabClinical trials—Industry payments2Publications—Imbruvicageneric · IbrutinibClinical trials—Industry payments2Publications—Reblozylgeneric · LuspaterceptClinical trials—Industry payments2Publications—Darzalexgeneric · DaratumumabClinical trials—Industry payments1Publications—Fotivdageneric · TivozanibClinical trials—Industry payments1Publications—Kisqaligeneric · RibociclibClinical trials—Industry payments1Publications—LanreotideClinical trials—Industry payments1Publications—Lenvimageneric · LenvatinibClinical trials—Industry payments1Publications—Ninlarogeneric · IxazomibClinical trials—Industry payments1Publications—Onivydegeneric · IrinotecanClinical trials—Industry payments1Publications—Orgovyxgeneric · RelugolixClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments6AstraZeneca Pharmaceuticals LPClinical trials—Industry payments3Myriad Genetic Laboratories, Inc.Clinical trials—Industry payments3Celgene CorporationClinical trials—Industry payments2Janssen Biotech, Inc.Clinical trials—Industry payments2Seagen Inc.Clinical trials—Industry payments2Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments2Aveo Pharmaceuticals, Inc.Clinical trials—Industry payments1CTI BioPharma Corp.Clinical trials—Industry payments1Daiichi Sankyo Inc.Clinical trials—Industry payments1Eisai Inc.Clinical trials—Industry payments1Ipsen Biopharmaceuticals, IncClinical trials—Industry payments1Karolinska University HospitalClinical trials1Industry payments—Mylan Institutional Inc.Clinical trials—Industry payments1Myovant Sciences Inc.Clinical trials—Industry payments1Novartis Pharmaceuticals CorporationClinical trials—Industry payments1Pharmacyclics LLC, an AbbVie CompanyClinical trials—Industry payments1Sanford HealthClinical trials1Industry payments—Servier Pharmaceuticals LLCClinical trials—Industry payments1Universitaire Ziekenhuizen KU LeuvenClinical trials1Industry payments—University of EdinburghClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
17companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 12 Nov 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 12 Nov 2026

17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    100%
    Androgen Receptor Inhibitor62.9%
    Xtandi100%
    Part D≥13 patients
    Aromatase Inhibitor37.1%
    Anastrozole100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Background & recognition

Updated 12 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Awards & honors

honors on the public record
  • Board Member

    Oesophageal Cancer Fund

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.